Relmada Therapeutics (RLMD) Share-based Compensation (2014 - 2026)
Relmada Therapeutics' Share-based Compensation came in at $902,903 for Q2 2026, down 73.8% from $3.45 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Relmada Therapeutics reported Share-based Compensation of $8.74 million, down 59.7% year-over-year; for FY2025, it was $13.91 million, down 53.9% from FY2024.
- Share-based Compensation has declined in each of the last three years, with a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $30.18 million in FY2024 (-31.1%), $43.81 million in FY2023 (-0.9%), $44.19 million in FY2022 (+9.1%) and $40.49 million in FY2021 (+94.9%).
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation in data going back to Q4 2019.
- Year-over-year, Share-based Compensation has declined for 11 consecutive quarters, with an average decline of 53.3% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 475.4%), and the weakest in Q2 2026 (a decline of 73.8%).
- Business Quant data shows RLMD's Share-based Compensation at $956,186 (Q1 2026), $2.37 million (Q4 2025) and $4.51 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Relmada Therapeutics | 404.28 Mn | 404.28 Mn | - | 902,903.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 902,903.00 |
| Mar 31, 2026 | 956,186.00 |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 6.73 Mn |
| Sep 30, 2024 | 7.95 Mn |
| Jun 30, 2024 | 7.21 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 9.89 Mn |
| Sep 30, 2023 | 11.39 Mn |
| Jun 30, 2023 | 11.17 Mn |
| Mar 31, 2023 | 11.35 Mn |
| Dec 31, 2022 | 11.63 Mn |
| Sep 30, 2022 | 8.34 Mn |
| Jun 30, 2022 | 12.30 Mn |
| Mar 31, 2022 | 11.93 Mn |
| Dec 31, 2021 | 18.36 Mn |
| Sep 30, 2021 | 8.01 Mn |
API Access
Relmada Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();